Close Menu

Golden Helix

While the firm's customers will be able to use the module to conduct tertiary analysis of next-generation DNA-sequencing data, the tool could also benefit array users, particularly those using high-density chips in association studies.

The new module, which will provide an integrated desktop tool for tertiary analysis of next-generation DNA sequencing data, is the company's first for the NGS sector.

The company said that the next version of its SNP & Variation Suite software will be able to run on off-the-shelf GPUs and detect copy number variations 10 to 20 times faster on a GPU than on a similarly priced CPU.

New Products: Oct 26, 2010


Life Technologies' Exact Call Chemistry probe for SOLiD, Caliper's LabChip GX assay and Sciclone NGS Workstation, Adaptive TCR's immunoSEQ, Golden Helix's SNP and Variation Suite, GenBank 180.0

Vancouver, Canada-based Sirius Genomics is using arrays to develop a test to identify individuals who respond to the hormone vasopressin and similar compounds for the treatment of septic shock.

The two firms will partner to develop diagnostics to identify individuals who respond well to Vasopressin and other compounds for the treatment of septic shock and related conditions.

Golden Helix is working with Harvard to rewrite the code for an informatics tool for studying disease heritability in families.

Golden Helix's SNP and Variation software suite contains modules for copy-number analysis, whole-genome analysis, and regression, among others, which together enable researchers to manage and analyze genetic data.

CloudScientific will distribute Golden Helix's analytical services and proprietary software in China.

While the company's main customer group to date has been researchers conducting GWAS, it is targeting the latest version of its software to those using arrays in cytogenetics and agricultural biotechnology studies.


Russian CRISPR researcher moves along with plans to ultimately alter the genes of embryos of deaf couples, though awaits regulatory approval, Nature News reports.

University of California, San Francisco, researchers have uncovered a gene mutations that appears to make a father-son duo more efficient sleepers.

NPR reports a large health insurer has begun to cover some pharmacogenetic tests for psychiatric drugs.

In PLOS this week: genome-wide association study of non-syndromic orofacial cleft subtypes, epigenetic and transcriptomic analysis of pancreatic ductal adenocarcinoma, and more.